questions
Home » Archives for questions
“People don’t want to interact with our site they just want the basic information”
Wednesday, July 21st, 2010
In case of some of you were living in Siberia for the past 10 years: the Web is about interactivity not stagnant content. This is especially true for drug.com websites and if you’re just going to launch a site that is pretty much stagnant than save your money and buy a pizza for the team instead because you’re not going to make a difference in patients and consumers who visit your site. Earlier this year I received a call from a client who hired an interactive agency to build a great website for over $1 million
Posted in: DTC | 0 Comments »
Read the full story
Chronically ill using social networks but why ? Some recommendations on how to reach these people who want to connect
Thursday, March 25th, 2010
Chronically ill patients are going online for some good reasons; 1. Support: Often health care professionals don’t have the resources to provide patients with the emotional support they need and answer all their questions.
Posted in: DTC | 0 Comments »
Read the full story
#fdaSM Survey Results
Monday, March 1st, 2010
I worked all weekend to submit to the FDA the results of the Pharma Marketing News/Blog survey of readers about FDA’s Regulation of Drug & Device Promotion via the Internet & Social Media. As you may recall, the FDA asked for comments relating to the following 5 issues: Issue 1: Accountability Issue 2: Fulfilling Regulatory Requirements Issue 3: Posting Corrective Information Issue 4: Links Issue 5: Adverse Event Reporting Under each issue, the FDA included several specific questions for which it was seeking answers
Posted in: Social Media | 0 Comments »
Read the full story
A Few Pharma Companies Speak to FDA Social Media Docket
Monday, February 8th, 2010
On January 29th new documents appeared in the FDA's docket that has been devised to collect commentary after the November 12-13 Part 15 meeting on social media and the Internet and medical product marketing.
Read the full story
Investors Have Questions About Pharma’s Online Spending in 2010 and Beyond
Wednesday, December 16th, 2009
Investors who own stocks or who are thinking of buying stocks of major online Health sites are worried.
Read the full story
Dear FDA: Where Are the Public Comments Regarding Regulation of Internet, Docket FDA-2009-N-0441?
Wednesday, December 2nd, 2009
A public service message from FDA Intern: Not only does FDA Intern want to know where all the comments are, I want to know also! It’s been over 2 months since the FDA called for comments and three weeks since the public hearing. But there are NO comments available to view on the www.regulations.gov docket here .
Read the full story
Pre-Game Show – What Some of the Important Players Have to Say at the FDA Part 15 Meeting on Social Media
Wednesday, November 11th, 2009
This week a large number of people and entities released their presentations that will be given at the FDA Part 15 Meeting on Social Media and Medical Product Promotion to be held Thursday and Friday, November 12 and 13th at the National Transportation Safety Board in Washington, D.C.
Posted in: Regulatory | 0 Comments »
Read the full story
Social Media Best Practices for Pharma Are Needed, Whatever Happens at FDA
Thursday, October 29th, 2009
Many pharma eMarketing pundits and FDA policy wonks out there are already predicting that nothing much will come out of the upcoming public hearing on Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools (see ” FDA Announces Public Hearing on Promotion of Drugs on Internet & via Social Media. This is NOT a Hoax! “). Rich Meyer, blogger over at World of DTC Marketing , says “So what do I expect from the FDA open hearings?
Posted in: Traditional Channels | 0 Comments »
Read the full story
Are There Special Cases for Correcting Misinformation on Social Media Sites?
Saturday, October 10th, 2009
In preparation for FDA’s public hearing on the Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools, the agency is asking for comments on 19 specific questions (see ” Let’s Respond to FDA’s Questions Regarding Its Regulation of Social Media “). These questions are included in my ongong online survey/questionnaire, which you can access here .
Posted in: Traditional Channels | 0 Comments »
Read the full story
How Should Pharma Companies Submit Social Media Content for FDA Approval?
Friday, October 9th, 2009
In preparation for FDA’s public hearing on the Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools, the agency is asking for comments on 19 specific questions (see ” Let’s Respond to FDA’s Questions Regarding Its Regulation of Social Media “). These questions are included in my ongong online survey/questionnaire, which you can access here
Posted in: Traditional Channels | 0 Comments »
Read the full story
Business Week – Drug Marketing
Business Week – Pharma Marketing
Cafe Pharma
Clinical Trials.gov
FDA on Twitter
Pharma Live
Pharma Voice